SiCORE-CIT Research Accepted by ELSEVIER

The original research paper from Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT) entitled “Anti-Tumour Effect of the Fourth-Generation Chimeric Antigen Receptor T Cells Targeting CD133 Against Cholangiocarcinoma Cells” by Ms. Thanich Sangsuwannukul (First Author) and Prof. Pa-thai Yenchitsomanus (Corresponding Author) was accepted to be published in ELSEVIER‘s International Immunopharmacology!

The “International Immunopharmacology” is the primary publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology, and immunotoxicology.

#elseviers #irsiriraj #sirirajresearch